VIOME LIFE SCIENCES, INC.
Gut microbiome analysis platform with personalized nutrition recommendations and custom supplement formulation
- Sector
- Biotech
- Headquarters
- BELLEVUE, WA
- Founded
- 2016
- Latest Form D
- $25.4M, Aug 2024
- Total capital
- $152M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $152M
- 6 Form D · last Aug 2024
- 26 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 8
- 22 pending · first 2023
- Rank in peer group#28 of 342
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 6th filing$25.4M
- Private capital raisedForm D · SEC · 5th filing$67M
- Private capital raisedForm D · SEC · 4th filing$3M
- Private capital raisedForm D · SEC · 3rd filing$36.5M
- Private capital raisedForm D · SEC · 2nd filing$5.5M
- Private capital raisedForm D · SEC · 1st filing$15M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 342 peers
Line = medianBiotech · Platform
- Granted patents#28 · top 8%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alex A. MorganDirectorNamed in SEC Form D filings
- Christopher A. KitzeDirectorNamed in SEC Form D filings
- EIICHIRO A. KIMURADirectorNamed in SEC Form D filings
- Erik K AndersonDirectorNamed in SEC Form D filings
- GREGORY J. MOOREDirectorNamed in SEC Form D filings
- Naveen JainExecutive Officer, DirectorNamed in SEC Form D filings
Show all 9 people
- Steven W. SansomDirectorNamed in SEC Form D filings
- Teymour A. Boutros-GhaliDirectorNamed in SEC Form D filings
- William A. OwensDirectorNamed in SEC Form D filings
What it has protected
USPTO · 8 granted of 30- GrantedComputer Systems And Methods For Inferring Scores For Health MetricsUSPTOUS 12,744,108
- GrantedPersonalized Nutritional Supplements and Methods of MakingUSPTOUS 12,685,329
- GrantedPersonalizing Food Recommendations To Reduce Glycemic ResponseUSPTOUS 12,444,318
Show all 30 patent records
- Computer Systems And Methods For Inferring Scores For Health MetricsSep 22, 2026 · US 12,744,108Granted
- Personalized Nutritional Supplements and Methods of MakingJul 21, 2026 · US 12,685,329Granted
- Personalizing Food Recommendations To Reduce Glycemic ResponseOct 14, 2025 · US 12,444,318Granted
- Methods For Computational Analysis Of Biological Samples With Machine Learning Analysis And Systems For SameJul 17, 2025 · Application 18730737Pending
- Personalizing Food Recommendations To Reduce Glycemic ResponseApr 8, 2025 · US 12,272,262Granted
- Biomarkers for AgeFeb 27, 2025 · Application 18927728Pending
- Biomarker Database Generation And UseJan 23, 2025 · Application 18907353Pending
- Biomarkers for AgeDec 10, 2024 · US 12,165,745Granted
- Methods And Compositions For Processing Samples Containing Nucleic AcidsNov 28, 2024 · Application 18792380Pending
- Methods And Compositions For Processing Samples Containing Nucleic AcidsSep 10, 2024 · US 12,084,652Granted
- Personalized Nutritional Supplements and Methods of MakingJul 2, 2024 · US 12,022,853Granted
- Biomarker Database Generation and UseJun 20, 2024 · Application 18415763Pending
- Methods For And Compositions For Determining Food Item RecommendationsOct 10, 2023 · US 11,783,726Granted
- Diagnostic For Oral CancerMay 25, 2023 · Application 17915082Pending
- Sample Collection Device With ReagentDec 29, 2022 · Application 17779364Pending
- Detection And Elimination Of Aberrant CellsDec 15, 2022 · Application 17779439Pending
- Sample Collection Methods And DevicesJul 21, 2022 · Application 17616650Pending
- Methods For And Compositions For Determining Food Item RecommendationsDec 23, 2021 · Application 17283934Pending
- Systems And Methods For Microbiome AnalysisOct 28, 2021 · Application 17273463Pending
- Biomarker Database Generation and UseApr 18, 2019 · Application 16089019Pending
- Supplements For Supporting Gastrointestinal HealthApplication PCTUS2022029711Pending
- Methods And Compositions For Evaluating And Treating Blood Glucose DysregulationApplication PCTUS2022033693Pending
- Supplements For Supporting Metabolic FunctionApplication PCTUS2022029662Pending
- Personalized Nutritional Supplements And Methods Of MakingApplication PCTUS2021065823Pending
- Supplements For Supporting Mental HealthApplication PCTUS2022029702Pending
- Biomarkers For AgeApplication PCTUS2021049187Pending
- Methods And Compositions For Evaluating And Treating Blood Glucose DysregulationApplication 63210906Pending
- Diagnostic For Oral CancerApplication PCTUS2021024547Pending
- Detection And Elimination Of Aberrant CellsApplication PCTUS2020062495Pending
- Sample Collection Methods And DevicesApplication PCTUS2020070125Pending
Related companies, and why
- Vividion TherapeuticsSimilar federal contract value in Biotech · null in contracts
- AlumisSimilar federal contract value in Biotech · null in contracts
- AUCTUS BIOLOGICS, INC.Similar federal contract value in Biotech · null in contracts
- IMMUDX, LLCSimilar federal contract value in Biotech · null in contracts
- Quince TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Eton Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
Press
Viome Acquires Circulate Health To Combine Precision Diagnostics With Therapeutic Plasma ExchangePulse 2.0
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .